Oscotec Inc. Logo

Oscotec Inc.

039200.KQ

(0.0)
Stock Price

36.550,00 KRW

-14.62% ROA

-22.12% ROE

-39.28x PER

Market Cap.

788.168.000.000,00 KRW

0% DER

0% Yield

-490.4% NPM

Oscotec Inc. Stock Analysis

Oscotec Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Oscotec Inc. Fundamental Stock Analysis
# Analysis Rating
1 ROE

Unidentified ROE

2 ROA

Unidentified ROA

3 PBV

Unidentified ROA

4 DER

Unidentified DER

5 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

6 Net Profit Growth

This company's net profit has remained stagnant over the past five years, indicating a lack of growth and making it a less favorable investment option.

7 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

8 Graham Number

Unidentified Graham Number

9 Dividend Growth

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

10 Dividend

Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.

11 Buffet Intrinsic Value

The company's stock appears overvalued (0) by Warren Buffett's formula, suggesting a less favorable investment opportunity as its market price exceeds its estimated intrinsic value.

Oscotec Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Oscotec Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Hold

Oscotec Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Oscotec Inc. Revenue
Year Revenue Growth
2012 24.755.850.120
2013 21.858.819.380 -13.25%
2014 17.110.321.000 -27.75%
2015 18.335.817.610 6.68%
2016 3.553.891.400 -415.94%
2017 3.908.490.780 9.07%
2018 18.702.671.520 79.1%
2019 4.368.519.900 -328.12%
2020 43.470.793.390 89.95%
2021 3.902.734.750 -1013.85%
2022 5.062.376.480 22.91%
2023 7.201.120.160 29.7%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Oscotec Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2012 1.963.614.590
2013 2.371.881.170 17.21%
2014 2.140.564.220 -10.81%
2015 1.997.922.860 -7.14%
2016 6.546.561.000 69.48%
2017 4.820.977.750 -35.79%
2018 6.970.003.000 30.83%
2019 15.409.411.530 54.77%
2020 32.787.464.640 53%
2021 22.708.863.480 -44.38%
2022 23.342.823.650 2.72%
2023 23.828.399.280 2.04%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Oscotec Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2012 245.968.880
2013 176.081.620 -39.69%
2014 143.920.080 -22.35%
2015 146.698.770 1.89%
2016 68.723.840 -113.46%
2017 263.804.210 73.95%
2018 289.965.710 9.02%
2019 589.728.690 50.83%
2020 714.381.470 17.45%
2021 606.414.750 -17.8%
2022 882.843.950 31.31%
2023 647.027.200 -36.45%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Oscotec Inc. EBITDA
Year EBITDA Growth
2012 2.109.827.890
2013 -475.555.810 543.66%
2014 -344.289.740 -38.13%
2015 1.194.389.590 128.83%
2016 -6.264.588.810 119.07%
2017 -5.488.247.120 -14.15%
2018 6.485.539.790 184.62%
2019 -21.304.652.530 130.44%
2020 2.642.669.920 906.18%
2021 -26.552.299.430 109.95%
2022 -26.872.395.270 1.19%
2023 -25.791.367.240 -4.19%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Oscotec Inc. Gross Profit
Year Gross Profit Growth
2012 8.042.148.161
2013 9.266.326.190 13.21%
2014 7.504.839.330 -23.47%
2015 8.380.014.430 10.44%
2016 2.021.363.770 -314.57%
2017 2.167.496.070 6.74%
2018 16.205.149.140 86.62%
2019 2.179.390.500 -643.56%
2020 41.412.262.900 94.74%
2021 1.767.884.210 -2242.48%
2022 2.838.802.220 37.72%
2023 4.947.099.640 42.62%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Oscotec Inc. Net Profit
Year Net Profit Growth
2012 -14.476.368.760
2013 -3.970.862.400 -264.56%
2014 -2.022.401.030 -96.34%
2015 395.029.720 611.96%
2016 -8.850.911.870 104.46%
2017 -5.856.533.410 -51.13%
2018 3.370.819.416 273.74%
2019 -22.600.600.474 114.91%
2020 -4.356.524.900 -418.78%
2021 -26.262.553.020 83.41%
2022 -24.429.545.530 -7.5%
2023 -15.423.433.080 -58.39%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Oscotec Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2012 -811
2013 -183 -345.6%
2014 -90 -102.22%
2015 16 662.5%
2016 -349 104.6%
2017 -221 -58.18%
2018 124 278.86%
2019 -801 115.36%
2020 -145 -452.41%
2021 -866 83.26%
2022 -763 -13.5%
2023 -404 -88.86%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Oscotec Inc. Free Cashflow
Year Free Cashflow Growth
2012 3.051.510.820
2013 -1.409.128.640 316.55%
2014 -2.119.993.350 33.53%
2015 535.970.320 495.54%
2016 -8.248.322.040 106.5%
2017 -3.750.575.980 -119.92%
2018 -6.801.761.160 44.86%
2019 -4.163.485.669 -63.37%
2020 -23.103.795.050 81.98%
2021 -16.280.203.150 -41.91%
2022 -27.670.130.240 41.16%
2023 -7.308.476.650 -278.6%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Oscotec Inc. Operating Cashflow
Year Operating Cashflow Growth
2012 3.335.386.500
2013 -1.345.620.790 347.87%
2014 -1.962.080.260 31.42%
2015 645.418.560 404%
2016 -8.208.919.000 107.86%
2017 -3.689.052.800 -122.52%
2018 -5.077.994.130 27.35%
2019 27.468.800 18586.41%
2020 -17.881.396.370 100.15%
2021 -8.761.867.980 -104.08%
2022 -26.420.974.920 66.84%
2023 -7.033.128.900 -275.66%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Oscotec Inc. Capital Expenditure
Year Capital Expenditure Growth
2012 283.875.680
2013 63.507.850 -346.99%
2014 157.913.090 59.78%
2015 109.448.240 -44.28%
2016 39.403.040 -177.77%
2017 61.523.180 35.95%
2018 1.723.767.030 96.43%
2019 4.190.954.469 58.87%
2020 5.222.398.680 19.75%
2021 7.518.335.170 30.54%
2022 1.249.155.320 -501.87%
2023 275.347.750 -353.66%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Oscotec Inc. Equity
Year Equity Growth
2012 24.472.826.640
2013 22.165.349.960 -10.41%
2014 21.783.202.880 -1.75%
2015 26.917.977.220 19.08%
2016 16.553.358.000 -62.61%
2017 25.652.879.280 35.47%
2018 51.669.236.499 50.35%
2019 54.366.263.530 4.96%
2020 57.241.109.820 5.02%
2021 31.188.515.670 -83.53%
2022 121.821.006.020 74.4%
2023 111.773.480.859 -8.99%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Oscotec Inc. Assets
Year Assets Growth
2012 43.050.912.620
2013 37.647.732.390 -14.35%
2014 36.269.210.370 -3.8%
2015 49.498.623.010 26.73%
2016 28.605.942.000 -73.04%
2017 40.544.532.970 29.45%
2018 70.258.505.280 42.29%
2019 72.393.422.360 2.95%
2020 76.387.767.600 5.23%
2021 48.967.314.560 -56%
2022 143.735.698.270 65.93%
2023 138.496.442.750 -3.78%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Oscotec Inc. Liabilities
Year Liabilities Growth
2012 18.578.085.970
2013 15.482.382.430 -20%
2014 14.486.007.500 -6.88%
2015 22.580.645.790 35.85%
2016 12.052.584.150 -87.35%
2017 14.891.653.690 19.06%
2018 18.589.268.780 19.89%
2019 18.027.158.830 -3.12%
2020 19.146.657.780 5.85%
2021 17.778.798.890 -7.69%
2022 21.914.692.250 18.87%
2023 26.722.961.890 17.99%

Oscotec Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
142.38
Net Income per Share
-528.22
Price to Earning Ratio
-39.28x
Price To Sales Ratio
145x
POCF Ratio
-33.44
PFCF Ratio
-31.77
Price to Book Ratio
6.99
EV to Sales
144.01
EV Over EBITDA
-30.21
EV to Operating CashFlow
-33.04
EV to FreeCashFlow
-31.55
Earnings Yield
-0.03
FreeCashFlow Yield
-0.03
Market Cap
788,17 Bil.
Enterprise Value
782,77 Bil.
Graham Number
5941.48
Graham NetNet
2054.66

Income Statement Metrics

Net Income per Share
-528.22
Income Quality
1.17
ROE
-0.21
Return On Assets
-0.18
Return On Capital Employed
-0.33
Net Income per EBT
0.75
EBT Per Ebit
0.99
Ebit per Revenue
-6.6
Effective Tax Rate
0.14

Margins

Sales, General, & Administrative to Revenue
0.15
Research & Developement to Revenue
4.04
Stock Based Compensation to Revenue
0.03
Gross Profit Margin
0.25
Operating Profit Margin
-6.6
Pretax Profit Margin
-6.52
Net Profit Margin
-4.9

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-620.58
Free CashFlow per Share
-649.86
Capex to Operating CashFlow
0.05
Capex to Revenue
-0.21
Capex to Depreciation
-0.6
Return on Invested Capital
-0.24
Return on Tangible Assets
-0.15
Days Sales Outstanding
116.8
Days Payables Outstanding
72.38
Days of Inventory on Hand
285.68
Receivables Turnover
3.13
Payables Turnover
5.04
Inventory Turnover
1.28
Capex per Share
-29.28

Balance Sheet

Cash per Share
2.697,49
Book Value per Share
2.970,25
Tangible Book Value per Share
2912.72
Shareholders Equity per Share
2970.25
Interest Debt per Share
0
Debt to Equity
0
Debt to Assets
0
Net Debt to EBITDA
0.21
Current Ratio
4.53
Tangible Asset Value
111,20 Bil.
Net Current Asset Value
80,71 Bil.
Invested Capital
0
Working Capital
83,73 Bil.
Intangibles to Total Assets
0
Average Receivables
1,27 Bil.
Average Payables
0,59 Bil.
Average Inventory
1469404830
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Oscotec Inc. Dividends
Year Dividends Growth
2007 50
2008 25 -100%

Oscotec Inc. Profile

About Oscotec Inc.

Oscotec Inc. operates as a clinical stage drug discovery and development company. It develops SYK inhibitor that is in Phase IIa clinical trial to treat rheumatoid arthritis and immune thrombocytopenia; FLT3 inhibitor, which is in Phase I clinical trial for the treatment of acute myeloid leukemia; and EGFR double mutation inhibitor to treat non-small cell lung cancer, as well as Anti-Tau antibody, which is in preclinical Phase for the treatment of Alzheimer's disease. The company also offers dental health products, such as bone graft comprising InduCera, BioCera-F, and SynCeraII; and membrane consisting of LysoGide and CollaGuide. In addition, it provides functional ingredients comprises OPB for osteoporosis; AIF for arthritis; SGA that enhance bone growth; and PRF-K for perio diseases. The company was formerly known as Oscotec Co., Ltd and changed its name to Oscotec Inc. in June 1999. Oscotec Inc. was founded in 1988 and is based in Seongnam, South Korea.

CEO
Sung-Hee Son
Employee
50
Address
A Building, Korea Bio Park
Seongnam-si, 13488

Oscotec Inc. Executives & BODs

Oscotec Inc. Executives & BODs
# Name Age
1 Sung-Hee Son
Executive Officer
70
2 Su-Sung Lee
Executive Officer
70
3 Sung-Ho Park
Executive Officer
70
4 So-Jin Ahn
Executive Officer
70
5 Ju-Won Kim
Executive Officer
70
6 Jae-Sang Lee
Executive Officer
70
7 Se-Nyun Kim
Executive Officer
70
8 Seung-Chul Lee
Executive Officer
70
9 Hirose Dakashi
Executive Officer
70
10 Mr. Jeung-Keun Kim
Chief Executive Officer
70

Oscotec Inc. Competitors

Yuhan Corporation Logo
Yuhan Corporation

000100.KS

(2.5)
Hanall Biopharma Co.,Ltd Logo
Hanall Biopharma Co.,Ltd

009420.KS

(1.5)
Green Cross Corporation Logo
Green Cross Corporation

006280.KS

(2.0)
Genexine, Inc. Logo
Genexine, Inc.

095700.KQ

(0.0)